Alarcon CR, Goodarzi H, Lee H, Liu X, Tavazoie S, Tavazoie SF. HNRNPA2B1 is a mediator of m(6)A-dependent nuclear RNA processing events. Cell. 2015;162:1299–308. https://doi.org/10.1016/j.cell.2015.08.011.

Google Scholar 

Bai X, Wong CC, Pan Y, Chen H, Liu W, Zhai J, et al. Loss of YTHDF1 in gastric tumors restores sensitivity to antitumor immunity by recruiting mature dendritic cells. J Immunother Cancer. 2022. https://doi.org/10.1136/jitc-2021-003663.

Google Scholar 

Bartosovic M, Molares HC, Gregorova P, Hrossova D, Kudla G, Vanacova S. N6-methyladenosine demethylase FTO targets pre-mRNAs and regulates alternative splicing and 3’-end processing. Nucleic Acids Res. 2017;45:11356–70. https://doi.org/10.1093/nar/gkx778.

Google Scholar 

Chang M, Cui X, Sun Q, Wang Y, Liu J, Sun Z, et al. Lnc-PLCB1 is stabilized by METTL14 induced m6A modification and inhibits Helicobacter pylori mediated gastric cancer by destabilizing DDX21. Cancer Lett. 2024;588:216746. https://doi.org/10.1016/j.canlet.2024.216746.

Google Scholar 

Chen K, Lu Z, Wang X, Fu Y, Luo GZ, Liu N, et al. High-resolution N(6) -methyladenosine (m(6) A) map using photo-crosslinking-assisted m(6) A sequencing. Angew Chem Int Ed Engl. 2015;54:1587–90. https://doi.org/10.1002/anie.201410647.

Google Scholar 

Chen C, Zhai E, Liu Y, Qian Y, Zhao R, Ma Y, et al. ALKBH5-mediated CHAC1 depletion promotes malignant progression and decreases cisplatin-induced oxidative stress in gastric cancer. Cancer Cell Int. 2023;23:293. https://doi.org/10.1186/s12935-023-03129-9.

Google Scholar 

Chen Q, Ao L, Zhao Q, Tang L, Xiong Y, Yuan Y, et al. WTAP/YTHDF1-mediated m(6)A modification amplifies IFN-γ-induced immunosuppressive properties of human MSCs. J Adv Res. 2025a;71:441–55. https://doi.org/10.1016/j.jare.2024.06.019.

Google Scholar 

Chen S, Li T, Liu D, Liu Y, Long Z, Wu Y, et al. Interaction of PHGDH with IGF2BP1 facilitates m6A-dependent stabilization of TCF7L2 mRNA to confer multidrug resistance in gastric cancer. Oncogene. 2025b;44:2064–77. https://doi.org/10.1038/s41388-025-03374-4.

Google Scholar 

Cheng S, Li H, Chi J, Zhao W, Lin J, Liu X, et al. FTO-mediated m(6)A modification promotes malignant transformation of gastric mucosal epithelial cells in chronic Cag A(+) Helicobacter pylori infection. J Cancer Res Clin Oncol. 2023;149:7327–40. https://doi.org/10.1007/s00432-023-04684-4.

Google Scholar 

Cui X, Chang M, Wang Y, Liu J, Sun Z, Sun Q, et al. Helicobacter pylori reduces METTL14-mediated VAMP3 m(6)A modification and promotes the development of gastric cancer by regulating LC3C-mediated c-Met recycling. Cell Death Discov. 2025a;11:13. https://doi.org/10.1038/s41420-025-02289-z.

Google Scholar 

Cui Y, Liu J, Wang X, Wu Y, Chang Y, Hu X, et al. Baicalin attenuates the immune escape of oral squamous cell carcinoma by reducing lactate accumulation in tumor microenvironment. J Adv Res. 2025b;77:721–32. https://doi.org/10.1016/j.jare.2025.01.021.

Google Scholar 

De Kesel J, Fijalkowski I, Pieters T, Borin C, Christensen KT, Wittouck M, et al. HNRNPC and m6A RNA methylation control oncogenic transcription and metabolism in T-cell leukemia. Blood. 2025;146:275–90. https://doi.org/10.1182/blood.2024026848.

Google Scholar 

Debruyne PR, Witek M, Gong L, Birbe R, Chervoneva I, Jin T, et al. Bile acids induce ectopic expression of intestinal guanylyl cyclase C through nuclear factor-kappaB and Cdx2 in human esophageal cells. Gastroenterology. 2006;130:1191–206. https://doi.org/10.1053/j.gastro.2005.12.032.

Google Scholar 

Deng X, Qing Y, Horne D, Huang H, Chen J. The roles and implications of RNA m(6)A modification in cancer. Nat Rev Clin Oncol. 2023;20:507–26. https://doi.org/10.1038/s41571-023-00774-x.

Google Scholar 

Dominissini D, Moshitch-Moshkovitz S, Schwartz S, Salmon-Divon M, Ungar L, Osenberg S, et al. Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq. Nature. 2012;485:201–6. https://doi.org/10.1038/nature11112.

Google Scholar 

Fan HN, Chen ZY, Chen XY, Chen M, Yi YC, Zhu JS, et al. METTL14-mediated m(6)A modification of circORC5 suppresses gastric cancer progression by regulating miR-30c-2-3p/AKT1S1 axis. Mol Cancer. 2022;21:51. https://doi.org/10.1186/s12943-022-01521-z.

Google Scholar 

Fang Y, Wu X, Gu Y, Shi R, Yu T, Pan Y, et al. LINC00659 cooperated with ALKBH5 to accelerate gastric cancer progression by stabilising JAK1 mRNA in an m(6) A-YTHDF2-dependent manner. Clin Transl Med. 2023;13:e1205. https://doi.org/10.1002/ctm2.1205.

Google Scholar 

Fang M, Li Y, Wang P, Wang Y, Wang X, Wa X, et al. METTL3 inhibition restores PD-L1 expression and CD8+ T-cell cytotoxic function in immunotherapy-treated gastric cancer. Cancer Immunol Res. 2025;13:1037–52. https://doi.org/10.1158/2326-6066.Cir-24-1179.

Google Scholar 

Ge L, Zhang N, Chen Z, Song J, Wu Y, Li Z, et al. Level of N6-methyladenosine in peripheral blood RNA: a novel predictive biomarker for gastric cancer. Clin Chem. 2020;66:342–51. https://doi.org/10.1093/clinchem/hvz004.

Google Scholar 

Ge L, Rui Y, Wang C, Wu Y, Wang H, Wang J. The RNA m(6)A reader IGF2BP3 regulates NFAT1/IRF1 axis-mediated anti-tumor activity in gastric cancer. Cell Death Dis. 2024;15:192. https://doi.org/10.1038/s41419-024-06566-0.

Google Scholar 

Han S, Jiang H, Wang J, Li C, Liu T, Xuan M, et al. WTAP-mediated N6-methyladenosine modification promotes gastric cancer progression by regulating MAP2K6 expression. J Cancer. 2025;16:1420–37. https://doi.org/10.7150/jca.98559.

Google Scholar 

He B, Hu Y, Wu Y, Wang C, Gao L, Gong C, et al. Helicobacter pylori CagA elevates FTO to induce gastric cancer progression via a “hit-and-run” paradigm. Cancer Commun (Lond). 2025;45:608–31. https://doi.org/10.1002/cac2.70004.

Google Scholar 

Hendra C, Pratanwanich PN, Wan YK, Goh WSS, Thiery A, Göke J. Detection of m6A from direct RNA sequencing using a multiple instance learning framework. Nat Methods. 2022;19:1590–8. https://doi.org/10.1038/s41592-022-01666-1.

Google Scholar 

Hsu PJ, Zhu Y, Ma H, Guo Y, Shi X, Liu Y, et al. Ythdc2 is an N(6)-methyladenosine binding protein that regulates mammalian spermatogenesis. Cell Res. 2017;27:1115–27. https://doi.org/10.1038/cr.2017.99.

Google Scholar 

Hu Y, Gong C, Li Z, Liu J, Chen Y, Huang Y, et al. Demethylase ALKBH5 suppresses invasion of gastric cancer via PKMYT1 m6A modification. Mol Cancer. 2022;21:34. https://doi.org/10.1186/s12943-022-01522-y.

Google Scholar 

Hu F, Zhang S, Chai J. METTL3 promotes gastric cancer progression via modulation of FNTA-mediated KRAS/ERK signaling activation. Mol Cancer Res. 2025. https://doi.org/10.1158/1541-7786.Mcr-24-1168.

Google Scholar 

Huang H, Weng H, Sun W, Qin X, Shi H, Wu H, et al. Recognition of RNA N(6)-methyladenosine by IGF2BP proteins enhances mRNA stability and translation. Nat Cell Biol. 2018;20:285–95. https://doi.org/10.1038/s41556-018-0045-z.

Google Scholar 

Huff S, Kummetha IR, Zhang L, Wang L, Bray W, Yin J, et al. Rational design and optimization of m(6)A-RNA demethylase FTO inhibitors as anticancer agents. J Med Chem. 2022;65:10920–37. https://doi.org/10.1021/acs.jmedchem.1c02075.

Google Scholar 

Huo FC, Zhu ZM, Zhu WT, Du QY, Liang J, Mou J. METTL3-mediated m(6)A methylation of SPHK2 promotes gastric cancer progression by targeting KLF2. Oncogene. 2021;40:2968–81. https://doi.org/10.1038/s41388-021-01753-1.

Google Scholar 

Hwang K, Bae J, Jhe YL, Kim J, Cheong JH, Choi HS, et al. Targeted degradation of METTL3 against acute myeloid leukemia and gastric cancer. Eur J Med Chem. 2024;279:116843. https://doi.org/10.1016/j.ejmech.2024.116843.

Google Scholar 

Jang D, Hwa C, Kim S, Oh J, Shin S, Lee SJ, et al. RNA N(6)-methyladenosine-binding protein YTHDFs redundantly attenuate cancer immunity by downregulating IFN-γ signaling in gastric cancer. Adv Sci Weinh. 2025;12:e2410806. https://doi.org/10.1002/advs.202410806.

Google Scholar 

Ji R, Wu C, Yao J, Xu J, Lin J, Gu H, et al. IGF2BP2-meidated m(6)A modification of CSF2 reprograms MSC to promote gastric cancer progression. Cell Death Dis. 2023;14:693. https://doi.org/10.1038/s41419-023-06163-7.

Google Scholar 

Jia G, Fu Y, Zhao X, Dai Q, Zheng G, Yang Y, et al. N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nat Chem Biol. 2011;7:885–7. https://doi.org/10.1038/nchembio.687.

Google Scholar 

Jia Y, Yan Q, Zheng Y, Li L, Zhang B, Chang Z, et al. Long non-coding RNA NEAT1 mediated RPRD1B stability facilitates fatty acid metabolism and lymph node metastasis via c-Jun/c-Fos/SREBP1 axis in gastric cancer. J Exp Clin Cancer Res. 2022;41:287. https://doi.org/10.1186/s13046-022-02449-4.

Google Scholar 

Jiang T, Xia Y, Li Y, Lu C, Lin J, Shen Y, et al. TRIM29 promotes antitumor immunity through enhancing IGF2BP1 ubiquitination and subsequent PD-L1 downregulation in gastric cancer. Cancer Lett. 2024;581:216510. https://doi.org/10.1016/j.canlet.2023.216510.

Google Scholar 

Jin G, Song Y, Fang S, Yan M, Yang Z, Shao Y, et al. HnRNPU-mediated pathogenic alternative splicing drives gastric cancer progression. J Exp Clin Cancer Res. 2025;44:8. https://doi.org/10.1186/s13046-024-03264-9.

Google Scholar 

Kim KL, van Galen P, Hovestadt V, Rahme GJ, Andreishcheva EN, Shinde A, et al. Systematic detection of m(6)A-modified transcripts at single-molecule and single-cell resolution. Cell Rep Methods. 2021. https://doi.org/10.1016/j.crmeth.2021.100061.

Google Scholar 

Knuckles P, Lence T, Haussmann IU, Jacob D, Kreim N, Carl SH, et al. Zc3h13/Flacc is required for adenosine methylation by bridging the mRNA-binding factor Rbm15/Spenito to the m(6)A machinery component Wtap/Fl(2)d. Genes Dev. 2018;32:415–29. https://doi.org/10.1101/gad.309146.117.

Google Scholar 

Lan Q, Liu PY, Bell JL, Wang JY, Hüttelmaier S, Zhang XD, et al. The emerging roles of RNA m6A methylation and demethylation as critical regulators of tumorigenesis, drug sensitivity, and resistance. Cancer Res. 2021;81:3431–40.

Google Scholar 

Leger A, Amaral PP, Pandolfini L, Capitanchik C, Capraro F, Miano V, et al. RNA modifications detection by comparative Nanopore direct RNA sequencing. Nat Commun. 2021;12:7198. https://doi.org/10.1038/s41467-021-27393-3.

Google Scholar 

Li H, Su Q, Li B, Lan L, Wang C, Li W, et al. High expression of WTAP leads to poor prognosis of gastric cancer by influencing tumour-associated T lymphocyte infiltration. J Cell Mol Med. 2020;24:4452–65. https://doi.org/10.1111/jcmm.15104.

Google Scholar 

Li H, Wang C, Lan L, Yan L, Li W, Evans I, et al. METTL3 promotes oxaliplatin resistance of gastric cancer CD133+ stem cells by promoting PARP1 mRNA stability. Cell Mol Life Sci. 2022;79:135. https://doi.org/10.1007/s00018-022-04129-0.

Google Scholar 

Li J, Feng H, Zhu J, Yang K, Zhang G, Gu Y, et al. Gastric cancer derived exosomal THBS1 enhanced Vγ9Vδ2 T-cell function through activating RIG-I-like receptor signaling pathway in a N6-methyladenosine methylation dependent manner. Cancer Lett. 2023;576:216410. https://doi.org/10.1016/j.canlet.2023.216410.

Google Scholar 

Li S, Zhou J, Wang S, Yang Q, Nie S, Ji C, et al. N(6)-methyladenosine-regulated exosome biogenesis orchestrates an immunosuppressive pre-metastatic niche in gastric cancer peritoneal metastasis. Cancer Commun. 2025.